Rate My Professor Zbigniew Szczepiorkowski

In addition to directing the Transfusion Medicine Fellowship Program and Transfusion Medicine Research Center, he is Section Chief of Laboratory Medicine/Clinical Pathology and Medical Director of the Blood Donor Program/Apheresis. His research interests include translational research on novel cellular therapies applied across medicine and evidence-based approaches to therapeutic apheresis. Szczepiorkowski has co-edited major texts including Apheresis: Principles and Practice (3rd edition, 2010) and Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians (2nd edition, 2015). Recent publications feature "Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines" (JAMA, 2025), "Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines" (Chest, 2024), and "Immunologic investigation of an allergic transfusion reaction suspected due to alpha-gal syndrome" (Transfusion, 2025). With over 8,000 Google Scholar citations, his contributions shape standards in transfusion medicine and cellular therapy. He chairs the FDA Blood Products Advisory Committee, served as President of the American Society for Apheresis, and holds board positions with organizations like ICCBBA. Awards include Top Doctor recognition by Castle Connolly (2024-2026).